The News Feed

News

Glaucomatous Eyes with High Systolic Blood Velocity May Progress Faster

This group of eyes studied showed the worst structural and functional markers.
May 10, 2024

Lipid-lowering Agents May Prevent DR Complications

An ARVO paper highlights the potential benefits of using statins in delaying progression to PDR.
May 9, 2024

Corneal Edema Post-Cataract More Common in Diabetic Patients

Age, disease status and race/ethnicity were linked to higher risk of issues after surgery.
May 9, 2024

DREAM Study Cohort Shows Dry Eye Test Repeatability Needs Improvement

Corneal and conjunctival staining scores were the most reliably consistent tests, while tear break-up time was the least.
May 9, 2024

Topical Insulin Eyedrops May Aid Corneal Healing

Re-epithelialization was faster and more successful with the treatment vs. conventional methods. Studies found positive effects in cases used for neurotrophic keratitis and ulcers.
May 8, 2024

Long-term Use of Anti-Glaucoma Meds Before SLT Linked to Adverse Effects

Higher age was predictive of failure, while a higher pre-SLT IOP was associated with a greater probability of success.
May 8, 2024

Study Links Reticular Pseudodrusen to Stroke Risk

Drusen didn’t show the same association, highlighting the distinct nature of the two findings.
May 8, 2024

Two ARVO Studies Note Influence of Genetic Testing in Glaucoma Onset

One paper helped isolate ocular hypertensives at a low risk of disease conversion. The other screened high- and low-risk patients and found a correlation between PRS and new diagnoses of POAG.
May 7, 2024

Corneal Complications Common in Pediatric Patients With Herpetic Keratoconjunctivitis

An ARVO paper focusing on ocular surface conditions in kids also shows high-potency corticosteroids were used most often in blepharokeratoconjunctivitis.
May 7, 2024

Two Studies Give Positive Marks to Pegcetacoplan Therapy for GA

Real-world results show that the drug reduced annual growth rate by about 34%. A clinical trial extension also reported a similar level of efficacy.
May 7, 2024